Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell × Contrast Media × 30 days × Clear all

Sponsor

Conditions

Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Paraganglioma 1 Papillary renal cell carcinoma, sporadic 1 Pancreatic Ductal Adenocarcinoma 1 Hereditary leiomyomatosis and renal cell cancer 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Ependymoma 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Cyclophosphamide 7 fludarabine 6 fludarabine phosphate 3 Specimen Handling 3 Rituximab 3 Magnetic Resonance Spectroscopy 3 zanubrutinib 2 polatuzumab vedotin 2 pirtobrutinib 2 obinutuzumab 2 glofitamab 2 Leukapheresis 2 Biopsy 2 tazemetostat 1 tafasitamab 1 pomalidomide 1 loncastuximab tesirine 1 ibrutinib 1 decitabine and cedazuridine drug combination 1 belinostat 1 axicabtagene ciloleucel 1 X-Rays 1 Vincristine 1 Prednisone 1 Pharmacokinetics 1 Pharmacogenomic Variants 1 Phantoms, Imaging 1 Nivolumab 1 MLN 8237 1 Lenalidomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡